Lin Xichen has filed 17 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 53703 shares of Structure Therapeutics Inc. ($GPCR) on March 19, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 53703 | $0.00 | 53,703.0000 | 177,596,000 | 9999.99% | 0.03% |
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Ordinary Shares | 43368 | $0.00 | 228,960.0000 | 177,596,000 | 23.37% | 0.02% |
| March 3, 2026 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | F | Ordinary Shares | 18735 | $20.99 | 185,592.0000 | 177,596,000 | 9.17% | 0.01% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | F | Ordinary Shares | 12846 | $6.84 | 204,327.0000 | 172,351,000 | 5.92% | 0.01% |
| March 1, 2025 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | F | Ordinary Shares | 6441 | $7.92 | 160,095.0000 | 157,922,000 | 3.87% | 0.00% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Ordinary Shares | 57078 | $0.00 | 217,173.0000 | 172,351,000 | 35.65% | 0.03% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Employee Stock Option (right to buy) | 196386 | $0.00 | 196,386.0000 | 157,922,000 | 9999.99% | 0.12% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Ordinary Shares | 80829 | $0.00 | 166,536.0000 | 157,922,000 | 94.31% | 0.05% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C | American Depositary Shares | 35400 | $0.00 | 35,400.0000 | 139,710,000 | 9999.99% | 0.03% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M | Ordinary Shares | 106200 | $0.34 | 191,907.0000 | 139,710,000 | 123.91% | 0.08% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C | Ordinary Shares | 106200 | $0.00 | 85,707.0000 | 139,710,000 | 55.34% | 0.08% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M | Share Option (right to buy) | 106200 | $0.00 | 213,800.0000 | 139,710,000 | 33.19% | 0.08% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S | American Depositary Shares | 17700 | $45.00 | 17,700.0000 | 139,710,000 | 50.00% | 0.01% |
| June 3, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S | American Depositary Shares | 17700 | $50.00 | 0.0000 | 139,710,000 | 100.00% | 0.01% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 213486 | $0.00 | 213,486.0000 | 110,198,000 | 9999.99% | 0.19% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Ordinary Shares | 85707 | $0.00 | 85,707.0000 | 110,198,000 | 9999.99% | 0.08% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Lin Xichen | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 213486 | $0.00 | 213,486.0000 | 110,198,000 | 9999.99% | 0.19% |